Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04878952 · ClinicalTrials.gov registry record · NA
Testing the Addition of Activity Monitoring With a Wearable Electronic Device to Improve Patient Care During Treatment for Lung Cancer
A NA study, sponsored by NRG Oncology.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT04878952 is a NA study that was terminated before completion, run by NRG Oncology. The registered enrollment target is 3 participants.
The verdict
NCT04878952, a NA study, was terminated before completion, sponsored by NRG Oncology.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
This trial will examine if the monitoring of daily step counts during a course of concurrent chemoradiotherapy for locally advanced non-small cell lung cancer will enable clinicians to deliver improved supportive care and reduce the rate of adverse events during the course of radiation treatment.
Interventions
- OTHER Garmin Vivofit Activity Tracker
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2021-08-26 |
| Est. Completion | 2024-08-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04878952
The ClinicalTrials.gov registry entry for NCT04878952 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NRG Oncology, which has 64 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Garmin Vivofit Activity Tracker is the first listed.
NCT04878952 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04878952 about?
NCT04878952 is a clinical study titled "Testing the Addition of Activity Monitoring With a Wearable Electronic Device to Improve Patient Care During Treatment for Lung Cancer". This trial will examine if the monitoring of daily step counts during a course of concurrent chemoradiotherapy for locally advanced non-small cell lung cancer will enable clinicians to deliver improved supportive care and reduce the rate of adverse events during the course of radiation treatment.
What is the current status of trial NCT04878952?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2021-08-26. Estimated completion is 2024-08-12.
What interventions are being tested in trial NCT04878952?
The interventions under investigation include: Garmin Vivofit Activity Tracker (OTHER).
Who is sponsoring clinical trial NCT04878952?
This trial is sponsored by NRG Oncology, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.